Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BOLT
BOLT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BOLT News
MAX Resource Corp. Completes Debt and Option Transactions with Bolt Metals
Jun 12 2026
Yahoo Finance
Bolt Biotherapeutics Q1 Earnings Miss Expectations Significantly
May 12 2026
seekingalpha
Bolt Biotherapeutics Q4 Earnings Beat Expectations
Mar 12 2026
seekingalpha
Bolt Announces Q3 2025 Financial Results and Updates on Oncology Pipeline Advancements
Nov 13 2025
NASDAQ.COM
HC Wainwright & Co. Initiates Coverage on Bolt Biotherapeutics with a Buy Rating and Sets Price Target at $7
Oct 20 2025
Benzinga
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
Apr 25 2025
Newsfilter
HC Wainwright & Co. Reiterates Neutral on Bolt Biotherapeuticsto Neutral
Mar 25 2025
Benzinga
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Mar 24 2025
Newsfilter
Bolt Biotherapeutics provides update on co-development collaboration with Toray
Feb 11 2025
Business Insider
Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates
Nov 12 2024
NASDAQ.COM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT
Sep 03 2024
PRnewswire
BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Sep 02 2024
Businesswire
BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Sep 02 2024
Globenewswire
BOLT DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Bolt Biotherapeutics, Inc. Investors to Secure Counsel Before Important September 3 Deadline in Securities Class Action – BOLT
Sep 01 2024
Globenewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt
Aug 31 2024
PRnewswire
BOLT Deadline: BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
Aug 30 2024
PRnewswire
Show More News
